Bio Path reported 35K in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Baxter International USD 58M 14M Sep/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Karyopharm Therapeutics USD 11.38M 2.43M Sep/2024